{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"76"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"51"}],"units":"Participants"}],"groups":[{"description":"XM02 Filgrastim (Granix) 10 mg/kg Days 1 through 4 (Days 5 through 8 may be required if target collection goal has not be met)\n\nPlerixafor 0.24 mg/kg Day 4 (Days 5 through 7 may be required if target collection goal has not be met)\n\nApheresis on Day 5 (may need to be done on Days 6-8 if target collection goal has not been met)","id":"OG000","title":"XM02 Filgrastim (Granix) and Plerixafor"},{"description":"Filgrastim (Neupogen) 10 mg/kg Days 1 through 4 (Days 5 through 8 may be required if target collection goal has not be met)\n\nPlerixafor 0.24 mg/kg Day 4 (Days 5 through 7 may be required if target collection goal has not be met)\n\nApheresis on Day 5 (may need to be done on Days 6-8 if target collection goal has not been met)","id":"OG001","title":"Filgrastim (Neupogen) and Plerixafor"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Day 5","title":"Comparison of the Percentage of Patients Who Collect > 5.0x10^6 CD34+Cells/kg in One Apheresis Procedure Following PBSC Mobilization Between the Two Arms","type":"SECONDARY","unitOfMeasure":"percentage of participants"}